Hainan Poly Pharm Co Ltd Working Capital to Net Assets Ratio
Hainan Poly Pharm Co Ltd working capital to net assets ratio. Hainan Poly Pharm Co Ltd (300630) has a Working Capital to Net Assets ratio of 27.9% as of September 2024. Working capital of CN¥784.27 Million (current assets of CN¥2.17 Billion minus current liabilities of CN¥1.39 Billion) is measured against net assets of CN¥2.81 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Hainan Poly Pharm Co Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Hainan Poly Pharm Co Ltd (2016–2023)
Working capital to net assets ratio of Hainan Poly Pharm Co Ltd from 2016 to 2023. This chart shows how Hainan Poly Pharm Co Ltd's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2016 to 2023. As of September 2024, the ratio stands at 27.9%, reflecting working capital of CN¥784.27 Million against net assets of CN¥2.81 Billion CNY. See 300630 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Hainan Poly Pharm Co Ltd Working Capital to Net Assets Ratio by Year (2016–2023)
Hainan Poly Pharm Co Ltd working capital to net assets ratio by year from 2016 to 2023. The table below presents the year-by-year Working Capital to Net Assets ratio for Hainan Poly Pharm Co Ltd from 2016 to 2023, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 300630 total asset value.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 21.7% | CN¥629.33 Million | CN¥2.91 Billion | CN¥2.28 Billion | CN¥1.65 Billion | ▼ -12.6 pp |
| 2022 | 34.2% | CN¥959.00 Million | CN¥2.80 Billion | CN¥2.44 Billion | CN¥1.48 Billion | ▼ -4.5 pp |
| 2021 | 38.8% | CN¥985.35 Million | CN¥2.54 Billion | CN¥2.03 Billion | CN¥1.04 Billion | ▲ +11.4 pp |
| 2020 | 27.4% | CN¥558.23 Million | CN¥2.04 Billion | CN¥1.23 Billion | CN¥674.56 Million | ▲ +6.0 pp |
| 2019 | 21.4% | CN¥245.14 Million | CN¥1.15 Billion | CN¥677.99 Million | CN¥432.85 Million | ▼ -9.8 pp |
| 2018 | 31.2% | CN¥275.50 Million | CN¥883.26 Million | CN¥439.30 Million | CN¥163.80 Million | ▼ -14.2 pp |
| 2017 | 45.4% | CN¥327.25 Million | CN¥721.37 Million | CN¥429.96 Million | CN¥102.71 Million | ▲ +5.6 pp |
| 2016 | 39.8% | CN¥122.21 Million | CN¥307.12 Million | CN¥174.59 Million | CN¥52.38 Million | — |